Good News on Lupus Nephritis Discoveries from ACR Convergence 2020
November 19, 2020
The LRA is proud to share the extraordinary work presented at ACR Convergence 2020 by research members...
Search Results
You searched for: lupus nephritis
Results found: 1120
LRA Congratulates GSK on FDA Approval of Benlysta® (belimumab) for Children with Lupus Nephritis
NEW YORK, NY. July 27, 2022. The Lupus Research Alliance (LRA) is pleased to share that the U.S. Food...
FDA Expedites Existing Drug Gazyva for Lupus Nephritis
September 18, 2019
The LRA is pleased to share that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy...
Lupus Research Alliance Applauds U.S. FDA Approval of Gazyva® (Obinutuzumab) for Lupus Nephritis
Only Treatment Option to Target Underlying Cause of Serious Lupus Complication, Aiming to Preserve Kidney Function The Lupus Research...
LRA-Supported Researchers Developed a Model to Predict Full-Blown Lupus Nephritis Down the Road
A new study funded by the Lupus Nephritis Trials Network with support from the Lupus Research Alliance has proposed...
Better Survival Rates from Severe Lupus Nephritis
September 20, 2018
Significantly more people are surviving end-stage renal (kidney) disease caused by lupus nephritis according to a long-term...
Encouraging Results with Obinutuzumab for Lupus Nephritis
February 13, 2022
The LRA is pleased to share a recently published paper reporting that the drug, obinutuzumab, showed positive...
Aurinia Announces Positive Long-Term Results on Lupykinis™ for Lupus Nephritis
December 9, 2021
The LRA is pleased to share positive topline three-year efficacy and safety results reported today by Aurinia...
LRA-Funded Research Uncovers a Novel Pathway for Lupus Nephritis
January 28, 2022
The investigators from The Accelerated Medicines Partnership® Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP® RA/SLE) Program, in...
Aurinia Moves Voclosporin Closer to FDA Approval for Lupus Nephritis
March 16, 2020
The Lupus Research Alliance is pleased to share an announcement from Aurinia Pharmaceuticals that moves its potential...
Lupus Therapeutics Partners to Evaluate Potential Treatment for SLE and Lupus Nephritis Through North American Trial Network
NEW YORK, NY, June 2, 2023 — Lupus Research Alliance clinical research affiliate Lupus Therapeutics will collaborate with Novartis...
Lupus Therapeutics Announces Collaboration to Support the Evaluation of Non-Genetically Modified Cell-Based Therapy for Lupus Nephritis with Artiva Biotherapeutics
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, announced a collaboration with Artiva Biotherapeutics, Inc. on...